HEADER COMPLEX (MHC I/PEPTIDE/CD8) 21-MAY-97 1AKJ TITLE COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL TITLE 2 CORECEPTOR CD8 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MHC CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (ALPHA COMPND 3 CHAIN); COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 6 SYNONYM: HLA-A2, HLA-A*0201; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BETA 2-MICROGLOBULIN; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 12 SYNONYM: HLA-A2, HLA-A*0201; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: HIV REVERSE TRANSCRIPTASE EPITOPE; COMPND 16 CHAIN: C; COMPND 17 FRAGMENT: PEPTIDE, RESIDUES 309 - 317; COMPND 18 ENGINEERED: YES; COMPND 19 MOL_ID: 4; COMPND 20 MOLECULE: T-CELL CORECEPTOR CD8; COMPND 21 CHAIN: D, E; COMPND 22 FRAGMENT: EXTRACELLULAR IGSF DOMAIN, RESIDUES 1 - 120, ALPHA CHAIN; COMPND 23 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: BL21; SOURCE 6 GENE: BETA-2-MICROGLOBULIN; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYSS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET23D; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: BJ075; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 CELL_LINE: BL21; SOURCE 17 GENE: BETA-2-MICROGLOBULIN; SOURCE 18 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 20 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYSS; SOURCE 21 EXPRESSION_SYSTEM_VECTOR: PET23D; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: BJ075; SOURCE 23 MOL_ID: 3; SOURCE 24 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS; SOURCE 25 ORGANISM_TAXID: 12721; SOURCE 26 MOL_ID: 4; SOURCE 27 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 28 ORGANISM_COMMON: HUMAN; SOURCE 29 ORGANISM_TAXID: 9606; SOURCE 30 CELL_LINE: BL21; SOURCE 31 GENE: BETA-2-MICROGLOBULIN; SOURCE 32 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 33 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 34 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYSS; SOURCE 35 EXPRESSION_SYSTEM_VECTOR: PGMT7; SOURCE 36 EXPRESSION_SYSTEM_PLASMID: BJ112 KEYWDS T-CELL, GLYCOPROTEIN, COMPLEX, IMMUNOLOGY, COMPLEX (MHC I-PEPTIDE- KEYWDS 2 CD8), COMPLEX (MHC I-PEPTIDE-CD8) COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.TORMO,D.I.STUART,E.Y.JONES REVDAT 4 02-AUG-23 1AKJ 1 REMARK REVDAT 3 24-FEB-09 1AKJ 1 VERSN REVDAT 2 01-APR-03 1AKJ 1 JRNL REVDAT 1 17-SEP-97 1AKJ 0 JRNL AUTH G.F.GAO,J.TORMO,U.C.GERTH,J.R.WYER,A.J.MCMICHAEL,D.I.STUART, JRNL AUTH 2 J.I.BELL,E.Y.JONES,B.K.JAKOBSEN JRNL TITL CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN JRNL TITL 2 CD8ALPHA(ALPHA) AND HLA-A2. JRNL REF NATURE V. 387 630 1997 JRNL REFN ISSN 0028-0836 JRNL PMID 9177355 JRNL DOI 10.1038/42523 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 21207 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1666 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3143 REMARK 3 BIN R VALUE (WORKING SET) : 0.3040 REMARK 3 BIN FREE R VALUE : 0.3580 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 293 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4957 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 108 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.41 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.51 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.040 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.750 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.920 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.570 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.830 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : RESTRAINTS REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : 0.04 ; 250 REMARK 3 GROUP 1 B-FACTOR (A**2) : 0.73 ; 1.00 REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM19.SOL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1AKJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170930. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-FEB-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21379 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09500 REMARK 200 FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.44000 REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRIES 3HLA, 1CD8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 12% PEG REMARK 280 20000, 100 MM MES, PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.45000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.80000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.45000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.80000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE B 1 REMARK 465 LYS D 115 REMARK 465 PRO D 116 REMARK 465 THR D 117 REMARK 465 THR D 118 REMARK 465 THR D 119 REMARK 465 PRO D 120 REMARK 465 LYS E 115 REMARK 465 PRO E 116 REMARK 465 THR E 117 REMARK 465 THR E 118 REMARK 465 THR E 119 REMARK 465 PRO E 120 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 17 -155.41 -122.76 REMARK 500 ASP A 29 -128.57 64.63 REMARK 500 TYR A 123 -62.29 -124.77 REMARK 500 ASP A 137 156.74 178.40 REMARK 500 HIS A 197 14.11 -147.06 REMARK 500 LYS A 243 147.98 -172.22 REMARK 500 ASN B 21 -153.60 -158.68 REMARK 500 HIS B 31 131.99 -177.27 REMARK 500 SER B 52 175.68 -59.14 REMARK 500 TRP B 60 -9.71 78.24 REMARK 500 THR B 73 -162.55 -110.25 REMARK 500 ASP D 9 42.28 -104.64 REMARK 500 ASN D 28 57.51 -112.95 REMARK 500 LEU D 49 -63.44 -120.90 REMARK 500 SER D 53 -150.08 -152.94 REMARK 500 ASP D 64 97.79 -68.97 REMARK 500 ASP D 83 65.48 63.26 REMARK 500 SER D 98 113.40 -170.43 REMARK 500 SER D 100 -16.78 70.85 REMARK 500 THR E 30 -31.73 -167.14 REMARK 500 SER E 31 56.30 -65.58 REMARK 500 ALA E 43 17.15 58.65 REMARK 500 LEU E 49 -65.13 -121.19 REMARK 500 ASP E 64 97.19 -68.29 REMARK 500 ASP E 83 65.16 60.72 REMARK 500 SER E 98 101.70 -163.00 REMARK 500 REMARK 500 REMARK: NULL DBREF 1AKJ A 1 276 UNP P01892 1A02_HUMAN 25 300 DBREF 1AKJ B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 1AKJ D 1 120 UNP P01732 CD8A_HUMAN 22 141 DBREF 1AKJ E 1 120 UNP P01732 CD8A_HUMAN 22 141 DBREF 1AKJ C 1 9 PDB 1AKJ 1AKJ 1 9 SEQRES 1 A 276 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 276 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 276 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 276 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 A 276 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 276 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 276 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 A 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 A 276 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 A 276 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 A 276 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 276 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 A 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 A 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 276 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 276 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 276 TRP GLU PRO SEQRES 1 B 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 B 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 B 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 B 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 B 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 B 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 B 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 ILE LEU LYS GLU PRO VAL HIS GLY VAL SEQRES 1 D 120 SER GLN PHE ARG VAL SER PRO LEU ASP ARG THR TRP ASN SEQRES 2 D 120 LEU GLY GLU THR VAL GLU LEU LYS CYS GLN VAL LEU LEU SEQRES 3 D 120 SER ASN PRO THR SER GLY CYS SER TRP LEU PHE GLN PRO SEQRES 4 D 120 ARG GLY ALA ALA ALA SER PRO THR PHE LEU LEU TYR LEU SEQRES 5 D 120 SER GLN ASN LYS PRO LYS ALA ALA GLU GLY LEU ASP THR SEQRES 6 D 120 GLN ARG PHE SER GLY LYS ARG LEU GLY ASP THR PHE VAL SEQRES 7 D 120 LEU THR LEU SER ASP PHE ARG ARG GLU ASN GLU GLY TYR SEQRES 8 D 120 TYR PHE CYS SER ALA LEU SER ASN SER ILE MET TYR PHE SEQRES 9 D 120 SER HIS PHE VAL PRO VAL PHE LEU PRO ALA LYS PRO THR SEQRES 10 D 120 THR THR PRO SEQRES 1 E 120 SER GLN PHE ARG VAL SER PRO LEU ASP ARG THR TRP ASN SEQRES 2 E 120 LEU GLY GLU THR VAL GLU LEU LYS CYS GLN VAL LEU LEU SEQRES 3 E 120 SER ASN PRO THR SER GLY CYS SER TRP LEU PHE GLN PRO SEQRES 4 E 120 ARG GLY ALA ALA ALA SER PRO THR PHE LEU LEU TYR LEU SEQRES 5 E 120 SER GLN ASN LYS PRO LYS ALA ALA GLU GLY LEU ASP THR SEQRES 6 E 120 GLN ARG PHE SER GLY LYS ARG LEU GLY ASP THR PHE VAL SEQRES 7 E 120 LEU THR LEU SER ASP PHE ARG ARG GLU ASN GLU GLY TYR SEQRES 8 E 120 TYR PHE CYS SER ALA LEU SER ASN SER ILE MET TYR PHE SEQRES 9 E 120 SER HIS PHE VAL PRO VAL PHE LEU PRO ALA LYS PRO THR SEQRES 10 E 120 THR THR PRO FORMUL 6 HOH *108(H2 O) HELIX 1 1 PRO A 50 GLU A 53 1 4 HELIX 2 2 PRO A 57 TYR A 84 1 28 HELIX 3 3 ALA A 139 ALA A 149 1 11 HELIX 4 4 VAL A 152 GLU A 161 1 10 HELIX 5 5 THR A 163 ASN A 174 1 12 HELIX 6 6 LYS A 176 LEU A 179 1 4 HELIX 7 7 GLU A 254 ARG A 256 5 3 HELIX 8 8 ARG D 86 ASN D 88 5 3 HELIX 9 9 ARG E 86 ASN E 88 5 3 SHEET 1 A 6 THR A 31 ASP A 37 0 SHEET 2 A 6 ARG A 21 VAL A 28 -1 N VAL A 28 O THR A 31 SHEET 3 A 6 HIS A 3 VAL A 12 -1 N VAL A 12 O ARG A 21 SHEET 4 A 6 THR A 94 VAL A 103 -1 N VAL A 103 O HIS A 3 SHEET 5 A 6 PHE A 109 TYR A 118 -1 N ALA A 117 O GLN A 96 SHEET 6 A 6 LYS A 121 ALA A 125 -1 N ILE A 124 O TYR A 116 SHEET 1 B 3 LYS A 243 PRO A 250 0 SHEET 2 B 3 GLU A 198 LEU A 206 -1 N ALA A 205 O LYS A 243 SHEET 3 B 3 LYS A 186 SER A 195 -1 N SER A 195 O GLU A 198 SHEET 1 C 3 ILE A 213 ARG A 219 0 SHEET 2 C 3 TYR A 257 HIS A 263 -1 N GLN A 262 O THR A 214 SHEET 3 C 3 LEU A 270 ARG A 273 -1 N LEU A 272 O CYS A 259 SHEET 1 D 3 LYS B 6 SER B 11 0 SHEET 2 D 3 SER B 20 SER B 28 -1 N SER B 28 O LYS B 6 SHEET 3 D 3 LEU B 64 THR B 71 -1 N PHE B 70 O ASN B 21 SHEET 1 E 3 ILE B 35 LYS B 41 0 SHEET 2 E 3 TYR B 78 HIS B 84 -1 N ASN B 83 O GLU B 36 SHEET 3 E 3 LYS B 91 LYS B 94 -1 N VAL B 93 O CYS B 80 SHEET 1 F 4 PHE D 3 SER D 6 0 SHEET 2 F 4 VAL D 18 VAL D 24 -1 N GLN D 23 O ARG D 4 SHEET 3 F 4 THR D 76 LEU D 81 -1 N LEU D 81 O VAL D 18 SHEET 4 F 4 PHE D 68 LEU D 73 -1 N LEU D 73 O THR D 76 SHEET 1 G 4 VAL D 108 VAL D 110 0 SHEET 2 G 4 GLY D 90 ALA D 96 -1 N TYR D 92 O VAL D 108 SHEET 3 G 4 CYS D 33 GLN D 38 -1 N GLN D 38 O TYR D 91 SHEET 4 G 4 THR D 47 LEU D 52 -1 N LEU D 52 O CYS D 33 SHEET 1 H 2 SER D 95 SER D 98 0 SHEET 2 H 2 ILE D 101 PHE D 104 -1 N TYR D 103 O ALA D 96 SHEET 1 I 4 PHE E 3 SER E 6 0 SHEET 2 I 4 VAL E 18 VAL E 24 -1 N GLN E 23 O ARG E 4 SHEET 3 I 4 THR E 76 LEU E 81 -1 N LEU E 81 O VAL E 18 SHEET 4 I 4 PHE E 68 LEU E 73 -1 N LEU E 73 O THR E 76 SHEET 1 J 4 VAL E 108 VAL E 110 0 SHEET 2 J 4 GLY E 90 SER E 95 -1 N TYR E 92 O VAL E 108 SHEET 3 J 4 CYS E 33 GLN E 38 -1 N GLN E 38 O TYR E 91 SHEET 4 J 4 THR E 47 LEU E 52 -1 N LEU E 52 O CYS E 33 SHEET 1 K 2 SER E 95 SER E 98 0 SHEET 2 K 2 ILE E 101 PHE E 104 -1 N TYR E 103 O ALA E 96 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.03 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.02 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 SSBOND 4 CYS D 22 CYS D 94 1555 1555 2.03 SSBOND 5 CYS E 22 CYS E 94 1555 1555 2.03 CISPEP 1 TYR A 209 PRO A 210 0 0.17 CISPEP 2 HIS B 31 PRO B 32 0 -0.37 CISPEP 3 GLU C 4 PRO C 5 0 -0.27 CISPEP 4 SER D 6 PRO D 7 0 -0.51 CISPEP 5 SER E 6 PRO E 7 0 -0.11 CRYST1 70.900 89.600 116.000 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014104 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011161 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008621 0.00000